Home/Investors/Sofinnova Partners

Sofinnova Partners

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$176.4M
Focus Areas
4
Top Stage
Phase 1/2

Portfolio Companies

CompanyValuation
Whitehawk Therapeutics$169.4M
Addex Therapeutics$7.0M